A pediatric case of resistant lichen planus pigmentosus treated with colchicine

Authors

  • Mehsas Zoubida Department of Dermatology and Venereology, Mohamed V University, Ibn Sina University Hospital, Rabat, Morocco
  • Sektaoui Soukaina Department of Dermatology and Venereology, Mohamed V University, Ibn Sina University Hospital, Rabat, Morocco
  • Boubnane Ibtissam Department of Dermatology and Venereology, Mohamed V University, Ibn Sina University Hospital, Rabat, Morocco
  • Znati Kaoutar Department of Histopathology, Mohamed V University, Ibn Sina University Hospital, Rabat, Morocco
  • Senouci Karima Department of Dermatology and Venereology, Mohamed V University, Ibn Sina University Hospital, Rabat, Morocco
  • Benzekri Laila Department of Histopathology, Mohamed V University, Ibn Sina University Hospital, Rabat, Morocco

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20231164

Keywords:

Lichen planus, Lichen pigmentosus, Pediatric, Colchicine

Abstract

This is a case report of a 8-year-old child with lichen planus pigmentosus (LPP), a rare subtype of pediatric lichen planus, successfully treated with colchicine after failure of other therapeutic options. Colchicine was introduced at a dose of 0.5mg/day for 1 year with sun protection, resulting in cessation of the eruption's extension and decrease in hyperpigmentation. No adverse effects were observed. This case highlights the potential of colchicine as a treatment option for pediatric patients with LPP, although further studies with larger sample sizes and longer follow-up periods are needed to establish its safety and effectiveness.

References

Pandhi D, Singal A, Bhattacharya SN. Lichen planus in childhood: a series of 316 patients. Pediatr Dermatol. 2014;31:59-67.

Krystal Mitchell, Nanette Silverberg. Systematic Review of Lichen Planus Pigmentosus in Children. J Drugs Dermatol. 2022;21(8):850-3.

Robles-Mendez JC. Lichen planus pigmentosus and its variants: review and update. Int J Dermatol. 2018;57:505-14.

Al-Mutairi N, El-Khalawany M. Clinicopathological character- istics of lichen planus pigmentosus and its response to tacrolimus ointment: An open label, non-randomized, prospective study. J Euro Academy Dermatol Venereol. 2010;24:535-40.

Terkeltaub RA. Down-regulates tumor necrosis factor-alpha (TNF-alpha) receptors (and TNF-alpha-driven responses) in macro- phages and endothelial cells. Seminars in Arthritis and Rheumatism. 2009;38:411-9.

Das A. Unconventional uses of common conventional drugs: A review. Indian J Dermatol Venereol Leprol. 2021;87:592-8.

Cozzani E. Could colchicine represent a new therapeutic approach for lichen planus pigmentosus? Dermatologic Therapy. 2019;32:e12809.

Downloads

Published

2023-04-27

Issue

Section

Case Reports